These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
837 related articles for article (PubMed ID: 19931120)
1. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia. Prechel MM; Jeske WP; Walenga JM Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120 [TBL] [Abstract][Full Text] [Related]
2. HITlights: a career perspective on heparin-induced thrombocytopenia. Warkentin TE Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928 [TBL] [Abstract][Full Text] [Related]
5. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT. Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492 [TBL] [Abstract][Full Text] [Related]
7. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis. Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366 [TBL] [Abstract][Full Text] [Related]
8. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Demma LJ; Winkler AM; Levy JH Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317 [TBL] [Abstract][Full Text] [Related]
9. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia. Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604 [TBL] [Abstract][Full Text] [Related]
10. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia. Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373 [TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367 [TBL] [Abstract][Full Text] [Related]
12. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex. Francis JL Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659 [TBL] [Abstract][Full Text] [Related]
13. Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primates. Ahmad S; Jeske WP; Walenga JM; Aldabbagh A; Iqbal O; Fareed J Thromb Res; 2000 Oct; 100(1):47-54. PubMed ID: 11053616 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia. Chong BH; Eisbacher M Semin Hematol; 1998 Oct; 35(4 Suppl 5):3-8; discussion 35-6. PubMed ID: 9855178 [TBL] [Abstract][Full Text] [Related]
16. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis. Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277 [TBL] [Abstract][Full Text] [Related]
19. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients. Kannan M; Saxena R; Adiguzel C; Fareed J Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409 [TBL] [Abstract][Full Text] [Related]
20. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis. Look KA; Sahud M; Flaherty S; Zehnder JL Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]